Intuitive Surgical Sees Unusually High Options Volume (NASDAQ:ISRG)

Intuitive Surgical, Inc. (NASDAQ:ISRG) saw unusually large options trading on Tuesday. Stock investors bought 8,950 put options on the company. This is an increase of approximately 27% compared to the average daily volume of 7,045 put options.

Analyst Ratings Changes

ISRG has been the subject of a number of recent research reports. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating for the company in a research report on Tuesday, June 2nd. HSBC cut their price objective on shares of Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. JPMorgan Chase & Co. reduced their target price on shares of Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Wall Street Zen upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday, June 13th. Finally, Royal Bank Of Canada lowered their price target on shares of Intuitive Surgical from $650.00 to $600.00 and set an “outperform” rating on the stock in a report on Monday. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $566.27.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analysts and market watchers still point to solid underlying business momentum, including strong da Vinci procedure growth, continued da Vinci 5 adoption, and expectations that Intuitive Surgical could beat Q2 earnings estimates. Article Title
• Positive Sentiment: Some commentary says the recent weakness reflects investor sentiment and valuation concerns more than company fundamentals, suggesting the long-term growth story remains intact. Article Title
• Neutral Sentiment: The company is heading into its July 16 earnings report, which is keeping traders on the sidelines and increasing volatility ahead of the release. Article Title
• Negative Sentiment: Fresh analyst price-target cuts, including TD Cowen’s reduction to $520 from $585, have reinforced concerns about valuation, competition, international-market challenges, and tariff pressure on margins. Article Title
• Negative Sentiment: The stock also saw unusually heavy put buying and a broader pullback in medtech names, signaling that some investors are positioning defensively ahead of earnings. Article Title

Intuitive Surgical Trading Down 6.8%

Intuitive Surgical stock opened at $379.50 on Wednesday. The firm has a market cap of $134.40 billion, a PE ratio of 46.00, a P/E/G ratio of 3.31 and a beta of 1.46. Intuitive Surgical has a 12 month low of $378.50 and a 12 month high of $603.88. The stock’s 50 day simple moving average is $419.65 and its two-hundred day simple moving average is $471.31.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The firm had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. During the same period in the previous year, the firm earned $1.81 EPS. The business’s quarterly revenue was up 23.0% on a year-over-year basis. On average, equities research analysts forecast that Intuitive Surgical will post 8.57 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Amy L. Ladd sold 119 shares of Intuitive Surgical stock in a transaction dated Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total transaction of $55,156.50. Following the completion of the sale, the director owned 120 shares of the company’s stock, valued at $55,620. The trade was a 49.79% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of the company’s stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the sale, the senior vice president owned 6,463 shares in the company, valued at approximately $2,718,014.65. This represents a 46.53% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 7,169 shares of company stock worth $3,059,135. 0.60% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Norges Bank purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth about $2,856,987,000. J. Stern & Co. LLP lifted its stake in Intuitive Surgical by 18,504.6% in the 4th quarter. J. Stern & Co. LLP now owns 2,127,248 shares of the medical equipment provider’s stock valued at $1,204,788,000 after buying an additional 2,115,814 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its stake in Intuitive Surgical by 1,043.3% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 1,342,121 shares of the medical equipment provider’s stock valued at $760,124,000 after buying an additional 1,224,734 shares in the last quarter. Arrowstreet Capital Limited Partnership boosted its holdings in Intuitive Surgical by 95.3% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock worth $970,635,000 after buying an additional 1,027,475 shares during the last quarter. Finally, Polen Capital Management LLC acquired a new stake in Intuitive Surgical in the 4th quarter worth about $477,225,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.